[Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
Terheyden
P
P
Universitäts-Hautklinik Würzburg.
Hofmann
U B
UB
Hamm
H
H
Bröcker
E B
EB
D017255:Acitretin / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002675:Child, Preschool; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D011701:PUVA Therapy; D010916:Pityriasis Rubra Pilaris / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011239:Prednisolone / Q000009:adverse effects*; D012176:Retinoids / Q000008:administration & dosage / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D012176:Retinoids; D011239:Prednisolone; D017255:Acitretin; D008727:Methotrexate